Synthesis of [18F]-1-(3-Fluoropropyl)-4-(4-cyanophenoxymethyl)-piperidine: A potential sigma-1 receptor radioligand for PET
β Scribed by T. Lee Collier; Joanne C. O'Brien; Rikki N. Waterhouse
- Publisher
- John Wiley and Sons
- Year
- 1996
- Tongue
- French
- Weight
- 467 KB
- Volume
- 38
- Category
- Article
- ISSN
- 0022-2135
No coin nor oath required. For personal study only.
β¦ Synopsis
~F]-1-(3-Fluoropropyl)-4-(4-cyanophenoxymethyl)piperidine has been prepared as a potential sigma-I receptor ligand for PET. The unlabeled ligand was found to be selective in vitro for the sigma-I receptor [Ki(crl) = 4.3 nM] when tested in a variety of neuroreceptor binding assays. Furthermore, the ligand is selective for sigma-I over sigma-2 receptors in vitro, having only moderate affinity for the sigma-2 receptor [Ki(a2) = 144 nM)]. The lipophilicity of the ligand (log P7.5 = 2.8) is appropriate for good brain uptake and low non-specific binding. Radiofluorination was accomplished using nucleophilic fluorination methods using an alkylmesylate precursor and the specific activity of the product was >74,000 MBq/pmole. The average radiochemical chemical yield after purification was 62.3 k 5.2% (56-70% EOB; n = 5) and the radiochemical purity of the product was >99%. The average time of synthesis and purification was 80 minutes.
π SIMILAR VOLUMES
The purpose of this study was to develop a radiopharmaceutical that could be used to selectively image 5-HT 1A receptors with positron emission tomography (PET). No-carrier-added 4-(28-methoxyphenyl)-1-[28-(N-29-pyridinyl)-p-[ 18 F]fluorobenzamido]ethylpiperazine ( p-[ 18 F]-MPPF, 2) was synthesized
The BTCP derivative l-[l-(2-benzo(b)thiophenyl) cyclohexyll-4-(2-hydroxyethyl) piperazine 2 showed, in uitro, high affinity and selectivity for the Dopamine transporter. In order to evaluate the potential of such a compound as an imaging tool for studying the dopaminergic system by Positron Emission